本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AVECHO BIOTECHNOLOGY LTD

0.008
-0.001-11.11%
成交量:339.74萬
成交額:3.04萬
市值:2,938.77萬
市盈率:-5.71
高:0.009
開:0.009
低:0.008
收:0.009
52周最高:0.012
52周最低:0.003
股本:36.73億
流通股本:18.96億
量比:0.38
換手率:0.18%
股息:- -
股息率:- -
每股收益(TTM):-0.001
每股收益(LYR):-0.001
淨資產收益率:-182.91%
總資產收益率:-40.85%
市淨率:18.84
市盈率(LYR):-5.71

資料載入中...

公司資料

公司名字:
AVECHO BIOTECHNOLOGY LTD
交易所:
ASX
成立時間:
1992
員工人數:
15
公司地址:
Hallmarc Business Park,Unit A8,2A Westall Road,Clayton,Victoria,Australia
郵編:
3168
傳真:
61 3 9002 5000
簡介:
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production, Human Health, and Animal Health and Nutrition segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company serves customers in Australia, Switzerland, the United States, India, Japan, China, Singapore, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited is based in Melbourne, Australia.